Publikationen von Lars Pelz
Alle Typen
Zeitschriftenartikel (6)
1.
Zeitschriftenartikel
108 (1), 240 (2024)
Production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration. Applied Microbiology and Biotechnology 2.
Zeitschriftenartikel
108, S. 1 - 15 (2024)
Production of antiviral “OP7 chimera” defective interfering particles free of infectious virus. Applied Microbiology and Biotechnology 3.
Zeitschriftenartikel
13, 20936 (2023)
Generation of “OP7 chimera” defective interfering influenza A particle preparations free of infectious virus that show antiviral efficacy in mice. Scientific Reports 4.
Zeitschriftenartikel
15 (9), 1872 (2023)
Broad-Spectrum Antiviral Activity of Influenza A Defective Interfering Particles against Respiratory Syncytial, Yellow Fever, and Zika Virus Replication In Vitro. Viruses 5.
Zeitschriftenartikel
95 (24), e01174-21 (2021)
Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy. Journal of Virology 6.
Zeitschriftenartikel
17, e1009357 (2021)
Multiscale model of defective interfering particle replication for influenza A virus infection in animal cell culture. PLoS Computational Biology Buchkapitel (2)
7.
Buchkapitel
Upstream processing for viral vaccines - Process intensification. In: Bioprocessing of Viral Vaccines, 1st edition Aufl., S. 137 - 174 (Hg. Kamen, A.; Cervera, L.). CRC Press, Boca Raton (2023)
8.
Buchkapitel
Upstream processing for viral vaccines – General aspects. In: Bioprocessing of Viral Vaccines, 1st edition Aufl., S. 79 - 136 (Hg. Kamen , A.; Cervera , L.). CRC Press, Boca Raton (2023)
Meeting Abstract (2)
9.
Meeting Abstract
53 (2) Special Issue: SI Aufl., P339. Joint Conference of the Société Française d'Immunologie (SFI) and the Deutsche Gesellschaft für Immunologie (DGfI), Strasbourg (France), 26. September 2023 - 29. September 2023. Wiley-VCH, Weinheim (2023)
Characterization of the local innate immune response after mucosal application of IAV Defective Interfering Particles. In European Journal of Immunology, 10.
Meeting Abstract
Scale-Down of an Ortbital Shaken Bioreactor: High Cell Density Cultivation in Perfusion Mode and Virus production. In Proceedings Single-Use Technologies V: Building the Future, 40. Single-Use Technologies V: Building the Future, Marseille, France, 20. März 2022 - 23. März 2022. (2022)
Vortrag (15)
11.
Vortrag
Engineered defective interfering particles of influenza A virus for antiviral treatment. 33rd Annual Meeting of the Society for Virology (GfV), Vienna (Austria) (2024)
12.
Vortrag
Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 17th Vaccine Congress, Glasgow (Scotland) (2023)
13.
Vortrag
Reverse genetics for Influenza a virus to generate genetically engineered defective interfering particles for antiviral treatment and vaccination. Vir-AI-DIP Workshop , Hamburg (Germany) (2023)
14.
Vortrag
Intensifiying OSB processes for high titer virus production. 5th large scale meeting: Orbital shaken bioreactors, Girona (Spain) (2023)
15.
Vortrag
Influenza A virus defective interfering particles as antiviral agents. 32nd Annual Meeting of the Society for Virology (GfV), Ulm (Germany) (2023)
16.
Vortrag
Influenza A virus OP7 defective interfering particles: Cell culture-based production and antiviral efficacy in vivo. Cell Culture Engineering (CCE) XVIII , Cancun (Mexico) (2023)
17.
Vortrag
In-depth characterization and cell culture-based production of influenza A virus defective interfering particles. ACTIP fellowship session, Dublin (Ireland) (2023)
18.
Vortrag
Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy. Vir-AI-DIP Workshop, Hamburg (Germany) (2023)
19.
Vortrag
Multiscale model of influenza A virus and defective interfering particle co-infection in animal cell culture. Vir-AI-DIP Workshop, Hamburg (Germany) (2023)
20.
Vortrag
Scale-Down of an Ortbital Shaken Bioreactor: High Cell Density Cultivation in Perfusion Mode and Virus production. Single-Use Technologies V: Building the Future, Marseille, France (2022)